Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye
Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye
- 眼科实践与研究新进展 2024年4卷第2期 页码：47-51
- 作者机构：
Eye Center of the Second Affiliated Hospital, Zhejiang University School of Medicine,Hangzhou,China
- 作者简介：
- 基金信息：
DOI：10.1016/j.aopr.2024.01.006
中图分类号：纸质出版日期：2024，
扫 描 看 全 文
Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye[J]. 眼科实践与研究新进展, 2024,4(2):47-51.
Lin Lin, Yirui Zhu, Kelan Yuan, et al. Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye[J]. AOPR, 2024,4(2):47-51.
Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye[J]. 眼科实践与研究新进展, 2024,4(2):47-51. DOI： 10.1016/j.aopr.2024.01.006.
Lin Lin, Yirui Zhu, Kelan Yuan, et al. Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye[J]. AOPR, 2024,4(2):47-51. DOI： 10.1016/j.aopr.2024.01.006.
摘要
Abstract
关键词
Keywords
references
1 E.J. Holland, M. Darvish, K.K. Nichols, L. Jones, P.M. KarpeckiEfficacy of topical ophthalmic drugs in the treatment of dry eye disease: a systematic literature review Ocul Surf, 17 (3) (Jul 2019), pp. 412-423, 10.1016/j.jtos.2019.02.012
2 M.M. Hom, A.L. Nguyen, L. BieloryAllergic conjunctivitis and dry eye syndrome Ann Allergy Asthma Immunol, 108 (3) (Mar 2012), pp. 163-166, 10.1016/j.anai.2012.01.006
3 K. Singh, S. Axelrod, L. BieloryThe epidemiology of ocular and nasal allergy in the United States, 1988-1994 J Allergy Clin Immunol, 126 (4) (Oct 2010), pp. 778-783 e6, 10.1016/j.jaci.2010.06.050
4 A.M. IraniOcular mast cells and mediators Immunol Allergy Clin, 28 (1) (Feb 2008), pp. 25-42, 10.1016/j.iac.2007.12.006
5 J.D. Nelson, J.P. Craig, E.K. Akpek, et al.TFOS DEWS II introduction Ocul Surf, 15 (3) (Jul 2017), pp. 269-275, 10.1016/j.jtos.2017.05.005
6 A. Kubicka-Trzaska, B. Romanowska-Dixon[Dry eye syndrome and allergic conjunctivitis-epidemics of XXI century-diagnostic problems and management] Przegl Lek, 66 (11) (2009), pp. 967-971 Zespol suchego oka i alergiczny niezyt spojowek-epidemie XXI wieku-problemy diagnostyczne i leczenie
7 The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international dry eye WorkShop Ocul Surf, 5 (2) (2007), pp. 93-107, 10.1016/s1542-0124(12)70082-4 Apr 2007
8 L. Chen, L. Pi, J. Fang, X. Chen, N. Ke, Q. LiuHigh incidence of dry eye in young children with allergic conjunctivitis in Southwest China Acta Ophthalmol, 94 (8) (Dec 2016), pp. e727-e730, 10.1111/aos.13093
9 M.S. Cowlen, V.Z. Zhang, L. Warnock, C.F. Moyer, W.M. Peterson, B.R. YerxaLocalization of ocular P2Y2 receptor gene expression by in situ hybridization Exp Eye Res, 77 (1) (Jul 2003), pp. 77-84, 10.1016/s0014-4835(03)00068-x
10 J.E. Jumblatt, M.M. JumblattRegulation of ocular mucin secretion by P2Y2 nucleotide receptors in rabbit and human conjunctiva Exp Eye Res, 67 (3) (Sep 1998), pp. 341-346, 10.1006/exer.1998.0520
11 J. Tauber, W.F. Davitt, J.E. Bokosky, et al.Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye Cornea, 23 (8) (Nov 2004), pp. 784-792, 10.1097/01.ico.0000133993.14768.a9
12 O.C. Lau, C. Samarawickrama, S.E. SkalickyP2Y2 receptor agonists for the treatment of dry eye disease: a review Clin Ophthalmol, 8 (2014), pp. 327-334, 10.2147/OPTH.S39699
13 Z.G. Liu[Paying attention to the expert consensus on dry eye to standardize and promote the clinical diagnosis and treatment of dry eye] Zhonghua Yan Ke Za Zhi, 56 (10) (Oct 11 2020), pp. 726-729, 10.3760/cma.j.cn112142-20200714-00476
14 Cornea Group of Ophthalmology Branch of Chinese Medical A[Chinese expert consensus on keratoprosthesis procedure (2021)] Zhonghua Yan Ke Za Zhi, 57 (10) (Oct 11 2021), pp. 727-733, 10.3760/cma.j.cn112142-20210713-00333
15 L. Bielory, E.O. Meltzer, K.K. Nichols, R. Melton, R.K. Thomas, J.D. BartlettAn algorithm for the management of allergic conjunctivitis Allergy Asthma Proc, 34 (5) (Sep-Oct 2013), pp. 408-420, 10.2500/aap.2013.34.3695
16 L. Lobefalo, E. D'Antonio, L. Colangelo, et al.Dry eye in allergic conjunctivitis: role of inflammatory infiltrate Int J Immunopathol Pharmacol, 12 (3) (Jan-Apr 1999), pp. 133-137
17 S. Gulati, S. JainOcular pharmacology of tear film, dry eye, and allergic conjunctivitis Handb Exp Pharmacol, 242 (2017), pp. 97-118, 10.1007/164_2016_73
18 S. Suzuki, E. Goto, M. Dogru, et al.Tear film lipid layer alterations in allergic conjunctivitis Cornea, 25 (3) (Apr 2006), pp. 277-280, 10.1097/01.ico.0000178277.29010.bc
19 K. Gumus, D.H. CavanaghThe role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca Clin Ophthalmol, 3 (2009), pp. 57-67
20 K.K. Nichols, B. Yerxa, D.J. KellermanDiquafosol tetrasodium: a novel dry eye therapy Expet Opin Invest Drugs, 13 (1) (Jan 2004), pp. 47-54, 10.1517/13543784.13.1.47
21 T. Fujihara, T. Murakami, H. Fujita, M. Nakamura, K. NakataImprovement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model Invest Ophthalmol Vis Sci, 42 (1) (Jan 2001), pp. 96-100
22 T. Murakami, T. Fujihara, M. Nakamura, K. NakataP2Y(2) receptor stimulation increases tear fluid secretion in rabbits Curr Eye Res, 21 (4) (Oct 2000), pp. 782-787, 10.1076/ceyr.21.4.782.5550
23 S. Fukuoka, R. AritaIncrease in tear film lipid layer thickness after instillation of 3% diquafosol ophthalmic solution in healthy human eyes Ocul Surf, 15 (4) (Oct 2017), pp. 730-735, 10.1016/j.jtos.2017.03.005
24 Y. Zhang, Y. Qi, X. Xie, F. ZhangThe effect of 3% diquafosol on the improvement of ocular surface post cataract surgery: a meta-analysis for time of intervention Advances in Ophthalmology Practice and Research, 2 (3) (2022/11/01/2022), Article 100063, 10.1016/j.aopr.2022.100063
25 T. Onguchi, M. Dogru, N. Okada, et al.The impact of the onset time of atopic keratoconjunctivitis on the tear function and ocular surface findings Am J Ophthalmol, 141 (3) (Mar 2006), pp. 569-571, 10.1016/j.ajo.2005.09.032
26 M. Dogru, N. Asano-Kato, M. Tanaka, et al.Ocular surface and MUC5AC alterations in atopic patients with corneal shield ulcers Curr Eye Res, 30 (10) (Oct 2005), pp. 897-908, 10.1080/02713680500196715
27 Y. Hu, Y. Matsumoto, M. Dogru, et al.The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis Allergy, 62 (8) (Aug 2007), pp. 917-925, 10.1111/j.1398-9995.2007.01414.x
28 J.P. Craig, K.K. Nichols, E.K. Akpek, et al.TFOS DEWS II definition and classification report Ocul Surf, 15 (3) (Jul 2017), pp. 276-283, 10.1016/j.jtos.2017.05.008
29 K. Tsubota, N. Yokoi, J. Shimazaki, et al.New perspectives on dry eye definition and diagnosis: a consensus report by the asia dry eye society Ocul Surf, 15 (1) (Jan 2017), pp. 65-76, 10.1016/j.jtos.2016.09.003
30 I. Toda, J. Shimazaki, K. TsubotaDry eye with only decreased tear break-up time is sometimes associated with allergic conjunctivitis Ophthalmology, 102 (2) (Feb 1995), pp. 302-309, 10.1016/s0161-6420(95)31024-x
31 S. Shimazaki-Den, M. Dogru, K. Higa, J. ShimazakiSymptoms, visual function, and mucin expression of eyes with tear film instability Cornea, 32 (9) (Sep 2013), pp. 1211-1218, 10.1097/ICO.0b013e318295a2a5
32 Q. Liang, J. Li, S. Zhang, et al.Characterization of conjunctival microbiome dysbiosis associated with allergic conjunctivitis Allergy, 76 (2) (Feb 2021), pp. 596-600, 10.1111/all.14635
0
浏览量
0
下载量
0
CSCD
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备09064830号-19
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies